Assessment of Chemotherapy-Induced Peripheral Neuropathy and its Impact on Health-Related Quality of Life among Various Cancer Patients

ABSTRACT

Background: Cancer patients' Health-Related Quality of Life (HRQOL) could be substantially impaired by Chemotherapy-Induced Peripheral Neuropathy (CIPN). Hence, the present study is aimed to assess the prevalence of CIPN and its influence on HRQOL among various cancer patients.Materials and Methods: The study was a prospective observational cross-sectional study conducted in the Department of Medical Oncology, Sri Ramachandra Institute of Higher Education and Research (DU) from Jan 2023 to July 2023. A total of 125 patients treated with various chemotherapeutic drugs were included as per inclusion and exclusion criteria. Patients were evaluated for CIPN using a validated Self-Administered Leeds Assessment of Neuropathic Symptoms and Signs (SLANSS) questionnaire and the health-related quality of life was evaluated by using the European Organization for Research and Treatment of Cancer Chemotherapy-Induced Peripheral Neuropathy (EORTC-CIPN20) questionnaire.Results: The prevalence of chemotherapy-induced peripheral neuropathy was found to be 12%. Patients receiving chemotherapy experienced a significantly higher number of peripheral neuropathy-related complaints (p<0.001). Overall, the patients expressed that peripheral neuropathy had a detrimental impact on their quality of life, particularly with sensory and motor functions.Conclusion: Chemotherapeutic drug has the potential to cause the adverse effect of peripheral neuropathy. Particularly, antimetabolites and platinum derivative combination had reported a higher incidence of peripheral neuropathy (94.7%). Consequently, it has a detrimental impact on the health-related quality of life among cancer patients.

KEYWORDS

• CIPN
• Platinum
• Taxane
• Cisplatin
• Paclitaxel
• Vincristine

Showing references and in-text citations exactly as published.

• DOI10.5530/jyp.2024.16.103Copy

Copyright and licence

© 2026 Author(s)

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0

RELATED ARTICLES

Matched on section and article type within this issue of JYP.

• Article · VOLUME 16, ISSUE 4Antidiabetic, Antihyperlipidemic and Protective Effect of Cupressus sempervirens L. Leaves Extract in Streptozotocin Induced Diabetic RatsSunayana Vikhe, Apeksha S. Fulsundar, Rahul Vikhe · pp. 706-713Original ArticleSame type: Article
• Article · VOLUME 16, ISSUE 4EGFR-mTOR siRNA Loaded Immumonanoparticles for Targeted Chemotherapy of Triple Negative Breast CancerKrishnan Shalini, Rajavel Varatharajan, Hamid Shahrul, Palanimuthu Vasanth Raj, Venugopal Vijayan · pp. 714-724Original ArticleSame type: Article
• Article · VOLUME 16, ISSUE 4Synthesis, Molecular Docking, in silico Druglikeness: In vitro Cytotoxicity Study on MCF-7 Cell Line of Quinazolin-4-one ScaffoldKavitha K, Jothikanth V, Kaniga P, Manoj Kumar S, Revathi P, Esakiprasanth R, Mohan S, Gowri Shankar NL, Jubilee R, Srinithi M, Lokesh Kumar H · pp. 725-734Original ArticleSame type: Article
• Article · VOLUME 16, ISSUE 4Innovative Thiophene Schiff Bases: Synthesis and Evaluation as Antitubercular AgentsGanesh Paleti, Ashutosh Jena, Gokula Krishnu, Bharath Kumar Chagaleti, Dudhe Prashik Bhimarao, Shanthakumar Balakrishnan · pp. 735-744Original ArticleSame type: Article